2. Webster LA, Berman SM, Greenspan JR: Surveillance for gonorrhea and primary and secondary syphilis among adolescents, United States--1981-1991. MMWR 1993; 42: 1-11

3. Canada Dis Wkly Rep 1991; 17: 49-50

4. Gorwitz RJ, Nakashima AK, Moran JS, et al: Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae-United States, 1988-1991. The gonococcal isolate surveillance project study group. MMWR CDC Surveillance Summaries 1993; 42: 29-39

5. Allard R, Robert J, Turgeon P, et al: Predictors of asymptomatic gonorrhea among patients seen by private practitioners. Can Med Assoc J 1985; 133: 1135-1139, 1146

6. Phillips RS, Hanff PA, Wertheimer A, et al: Gonorrhea in women seen for routine gynecologic care: Criteria for testing. Am J Med 1988; 85: 177-182

7. Rosenthal GE, Mettler G, Pare S, et al: A new diagnostic index for predicting cervical infection with either Chlamydia trachomatis or Neisseria gonorrhoeae. J Gen Intern Med 1990; 5: 319-326

8. Goh BT, Varia KB, Ayliffe PF, et al: Diagnosis of gonorrhea by gram-stained smears and cultures in men and women: Role of the urethral smear. Sex Transm Dis 1985; 12: 135-139

9. Beebe JL: Physician utilization of a gonococcal antibody screening test. Sex Transm Dis 1983; 10: 195-197

10. Papapetropoulou M, Detorakis J, Arkoulis A, et al: Screening for asymptomatic gonorrhea in males: A comparison of four techniques. J Chemother 1990; 2: 37-39

11. Lieberman RW, Wheelock JB: The diagnosis of gonorrhea in a low-prevalence female population: Enzyme immunoassay versus culture. Obstet Gynecol 1987; 69: 743-746

12. Vlaspolder F, Mutsaers JA, Blog F, et al: Value of a DNA probe assay (Gen-Probe) compared with that of culture for diagnosis of gonococcal infection. J Clin Microbiol 1993; 31: 107-110

13. Hale YM, Melton ME, Lewis JS, et al: Evaluation of the PACE 2 Neisseria gonorrheae assay by three public health laboratories. J Clin Microbiol 1993; 31: 451-453

14. Handsfield HH, McCormack WM, Hook EW, et al: A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The gonorrhea treatment study group. N Engl J Med 1991; 325: 1337-1341

15. Smith BL, Mogabgab WJ, Dalu ZA, et al: Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea. Am J Med 1993; 94(3A): 81S-84S

16. Handsfield HH, McCuchan JA, Corey L, et al: Evaluation of new anti-infective drugs for the treatment of uncomplicated gonorrhea in adults and adolescents. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992; 15 Suppl: S123-S130

17. Bewley S: Who defaults after treatment for gonorrhoea? Randomised controlled study of effect of an educational leaflet. Genitourin Med 1988; 64: 241-244

18. Blonna R, Legos P, Burlack P: The effects of an STD educational intervention on follow-up appointment keeping and medication-taking compliance. Sex Transm Dis 1989; 16: 198-200

19. Solomon MZ, deJong W: The impact of a clinic-based educational videotape on knowledge and treatment behavior of men with gonorrhea. Sex Transm Dis 1988; 15: 127-132

20. Condoms for prevention of sexually transmitted diseases. MMWR 1988; 37: 133-137

21. Louv WC, Austin H, Alexander WJ, et al: A clinical trial of Nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158: 518-523

22. U.S Preventive Services Task Force: Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Williams & Wilkins, Baltimore, Md, 1989: 135-137, 331-336

23. Interim guidelines for the treatment of uncomplicated gonococcal infection. Can Med Assoc J 1992; 146: 1587-8, 1591-1592